Cargando…

Pronounced State-Level Disparities in Prescription of Cannabinoids to Medicaid Patients

INTRODUCTION: Dronabinol is approved in the USA for chemotherapy-induced nausea as well as vomiting and HIV-induced anorexia, while cannabidiol is primarily approved for childhood epileptic disorders Lennox-Gastaut and Dravet syndrome. The use pattern for these prescription cannabinoids in the USA i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Edward Y., McCall, Kenneth L., Piper, Brian J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Preclinical Science and Clinical Studies – Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315157/ https://www.ncbi.nlm.nih.gov/pubmed/37404688 http://dx.doi.org/10.1159/000531058

Ejemplares similares

Declines and pronounced regional disparities in meperidine use in the United States
por: Boyle, John M., et al.
Publicado: (2021)

Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United States
por: Vaddadi, Sneha M., et al.
Publicado: (2021)

Chronic exposure to cannabinoids during adolescence causes long‐lasting behavioral deficits in adult mice
por: Tomas‐Roig, J, et al.
Publicado: (2016)

Disruption of hippocampal synaptic transmission and long‐term potentiation by psychoactive synthetic cannabinoid ‘Spice’ compounds: comparison with Δ(9)‐tetrahydrocannabinol
por: Hoffman, Alexander F., et al.
Publicado: (2016)

Pronounced Declines in Meperidine in the US: Is the End Imminent?
por: Harrison, Lavinia R., et al.
Publicado: (2022)

A tool to predict disparities in the timeliness of surgical treatment for breast cancer patients in the USA
por: Verdone, Christopher G., et al.
Publicado: (2022)

Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016
por: Piper, Brian J., et al.
Publicado: (2018)

Variation in adverse drug events of opioids in the United States
por: Liu, Edward Y., et al.
Publicado: (2023)

An analysis of patterns of distribution of buprenorphine in the United States using ARCOS, Medicaid, and Medicare databases
por: Hsu, Zhi‐Shan, et al.
Publicado: (2023)

Dynamic changes in prescription opioids from 2006 to 2017 in Texas
por: Ighodaro, Ebuwa O., et al.
Publicado: (2019)

Abstract 1 Distinctive and Differentiation-State Dependent DNA Damage Response of Hematopoietic Stem Cells to Genotoxic Noxae
por: Becker, Fabienne, et al.
Publicado: (2022)

Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin
por: Turturro, Sanja B., et al.
Publicado: (2016)

Baclofen decreases compulsive alcohol drinking in rats characterized by reduced levels of GAT‐3 in the central amygdala
por: Marti‐Prats, Lucia, et al.
Publicado: (2021)

Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer
por: Verma, Rashmi, et al.
Publicado: (2020)

Fast quantification of extracellular vesicles levels in early breast cancer patients by Single Molecule Detection Array (SiMoA)
por: Morasso, Carlo, et al.
Publicado: (2021)

Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis
por: Orucevic, Amila, et al.
Publicado: (2016)

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer
por: Jansen, M. P. H. M., et al.
Publicado: (2011)

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer
por: Lipton, Allan, et al.
Publicado: (2013)

Combination treatment of cancer cells with pan-Akt and pan-mTOR inhibitors: effects on cell cycle distribution, p-Akt expression level and radiolabelled-choline incorporation
por: Phyu, Su Myat, et al.
Publicado: (2018)

Abstract 22 Anomalous HLA-A Typing Found in Patient Using PacBio Sequencing Technology
por: Peavy, Lydia, et al.
Publicado: (2023)

Prescription Opioid Distribution after the Legalization of Recreational Marijuana in Colorado
por: Kropp Lopez, Amalie K., et al.
Publicado: (2020)

Contrast enhanced mammography in breast cancer surveillance
por: Elder, Kenneth, et al.
Publicado: (2023)

Micro-computed tomography enables rapid surgical margin assessment during breast conserving surgery (BCS): correlation of whole BCS micro-CT readings to final histopathology
por: McClatchy, David M., et al.
Publicado: (2018)

Cannabinoid(1) (CB-1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose
por: Skolnick, Phil, et al.
Publicado: (2019)

Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
por: Ma, Brigette B.Y., et al.
Publicado: (2009)

Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
por: Bostner, Josefine, et al.
Publicado: (2017)

Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic
por: Ahlborn, Lise B., et al.
Publicado: (2015)

Copper (II) complexes of bidentate ligands exhibit potent anti-cancer activity regardless of platinum sensitivity status
por: Wehbe, Mohamed, et al.
Publicado: (2017)

Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort
por: Cheng, Angela S., et al.
Publicado: (2019)

Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform
por: Wu, Natalie C., et al.
Publicado: (2018)

Dysregulation of the histone demethylase KDM6B in alcohol dependence is associated with epigenetic regulation of inflammatory signaling pathways
por: Johnstone, Andrea L., et al.
Publicado: (2019)

Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine
por: Gelbert, Lawrence M., et al.
Publicado: (2014)

Recurrent read-through fusion transcripts in breast cancer
por: Varley, Katherine E., et al.
Publicado: (2014)

Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy
por: Al-Subhi, Nouf, et al.
Publicado: (2018)

Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells
por: Dubash, Taronish D., et al.
Publicado: (2023)

Assessment of Controlled Substance Distribution to U.S. Veterinary Teaching Institutions From 2006 to 2019
por: Piper, Brian J., et al.
Publicado: (2020)

Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples
por: Wilson, Timothy R., et al.
Publicado: (2014)

Central carbon metabolism in the progression of mammary carcinoma
por: Richardson, Adam D., et al.
Publicado: (2007)

The spectrum of ATM missense variants and their contribution to contralateral breast cancer
por: Broeks, Annegien, et al.
Publicado: (2007)

Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases
por: Rajput, Ashish B., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_bgl71usgf049n0vrgkhn314c7f